Market Players Focus on Addressing Challenges Put Forward by Current Stent Modalities

Due to consistent advancements in the cardiovascular medicine field, stenting of the arteries has emerged as one of the most common and popular cardiovascular treatment. As stenting continues to gain popularity across the world, the demand for vascular stents continues to gain considerable traction. The alarming rise in the number of patients suffering from cardiovascular diseases has compelled the medical sector to focus on new treatments and medical concepts to improve the recovery rate of existing treatments. At present, existing technologies, particularly related to drug-eluting stents have witnessed rapid developments.

In addition, due to added research, these technologies continue to demonstrate high levels of efficacy and low rate of treatment failure due to which, applications of vascular stents continue to expand at a promising rate– a leading factor that is expected to drive the vascular stents market during the forecast period. Over the past few decades, participants operating in the vascular stents market are increasingly focusing on minimizing various complications involved with vascular stent implantations such as local chronic inflammation, in-stent restenosis, re-occlusion rates, and late thrombosis.

Considerable emphasis is being laid on various parameters of vascular stent development to facilitate long-term stability and assess various failure mechanisms. Currently, vascular stent technologies primarily focus on addressing the restenosis rate of high-risk patients in both, bare-metal stents as well as drug-eluting stents. At the back of these factors, along with growing demand for minimally invasive therapies, the global vascular stents market is expected to reach ~US$ 12 Bn by the end of 2027.

To know the scope of our report Get a Sample on Vascular Stents Market 

Drawbacks of First-generation Vascular Stents Result in Development of Advanced Products

The first-generation of vascular stents that were predominantly fabricated from cobalt-chromium, platinum-iridium, and stainless steel put forward an array of problems that led to tissue hyperplasia. Shortcomings and several other minor drawbacks of the first-generation of vascular stents accelerated the production of drug-eluting stents, biodegradable stents, and coated stents. Several vascular stent manufacturers are increasingly prioritizing the optimization of the physical-chemical, biological, and mechanical stent properties to attain the desired characteristics of various stents.

Some of the major developments and fabrication technologies in the vascular stents market are likely to focus on various properties, including expandability ration, compatibility with a balloon catheter, magnetic resonance imaging, flexibility, and thromboresistivity. The high mortality rate associated with cardiovascular diseases around the world coupled with innovative stent technology concepts has prompted clinicians and researchers to focus on the development of new techniques, materials, and solutions to enhance the clinical outcome of the currently deployed vascular stents.

Bioresorbable and Integrated Biosensor Technology to Redefine Future of Vascular Stents

As cardiovascular diseases continue to be among the leading causes of death around the world, consistent efforts are being made to address this looming medical problem. The existing anti-atherosclerotic and pharmacological modalities still fall short in controlling the disease due to which, enhancements in clinical interventions is the need of the hour. As a result of research, experts in the healthcare sector are of the opinion that bio-sensing devices offer immense promise in addressing in-stent restenosis. Moreover, due to the progress in nanofabrication, researchers continue to explore the various ways in which biosensors can be integrated into vascular stents to address the shortcomings of the existing stent modalities.

Get a glimpse of the in-depth analysis through our Report Brochure

The “Internet of Things” is expected to play a major role in the development of the next-generation of vascular stents. One of the recent developments across the vascular stents market that have gained considerable spotlight is the onset of bioresorbable stents. Analysts at Transparency Market Research predict that the adoption of bioresorbable stents is likely to witness considerable growth over the course of the forecast period due to the limitations of metal stents.

Demand to Fluctuate amid COVID-19 Pandemic, Product Diversification May Provide Short-term Gains

As the ongoing COVID-19 pandemic continues to derail the global economic growth, the medical sector continues to witness considerable movement. While the demand for personal protective equipment and other medical medicines and devices required for the treatment of the novel COVID-19 coronavirus is expected to skyrocket, the demand for vascular stents is likely to fluctuate due to lack of information regarding the potential impact of the virus on heart patients.

Several studies have suggested that individuals suffering from cardiovascular diseases are at a higher risk of contracting COVID-19 infection. While government regulations and guidelines continue to prioritize trade of COVID-19 medication and devices, the demand for vascular stents is likely to remain steady. Although it is hard to predict the demand pattern due to several external factors, the vascular stents market is expected to witness a lower growth rate compared with that of 2019.

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

The global vascular stents market is expected to grow at a moderate CAGR of ~5% during the forecast period. The considerable rise in the number of patients suffering from cardiovascular diseases, research & development activities, focus on improving the efficacy of existing stent technologies, and focus on the production of cutting-edge stents integrated with biosensors are some of the leading factors that will provide a boost to the growth of the vascular stents market during the forecast period. Market players should focus on research and development of new vascular stents that offer improved performance in comparison with first-generation stents fabricated from stainless steel and other metals. Biodegradable stents are likely to gain popularity in the upcoming years and could potentially replace vascular stents fabricated from metals.

Vascular Stents Market: Overview

  • This report analyzes the current and future prospects of the global vascular stents market. Rise in prevalence of cardiovascular diseases and increase in demand for minimally invasive surgeries are the key factors fueling the growth of the global vascular stents market during the forecast period.
  • The report provides an elaborate executive summary, which comprises a snapshot of various segments of the global vascular stents market. The report also provides information and data analysis of the global vascular stents market with regard to segments based on type, delivery method, material, end user, and region.
  • The overview section of the report provides detailed qualitative analysis of drivers and restraints impacting the global vascular stents market along with opportunities in the global market
  • Additionally, the global vascular stents market report includes company profiles and competitive matrix, which provide data about their businesses, product portfolios, and competitive landscape in the global vascular stents market
  • The report includes data analysis on the vascular stents market attractiveness by region and segments
  • The last section of the report provides quantitative and qualitative analysis on market share of key players operating in the global vascular stents market. It elaborates the key competitive strategies adopted by major industry players, thereby presenting a thorough understanding of the competitive scenario in the global vascular stents market.

Vascular Stents Market: Key Segments

  • In terms of type, the global vascular stents market has been segmented into coronary artery stents, peripheral vascular stents, and neurovascular stents. The coronary artery stents segment has been sub-segmented into bare metal stents, bioresorbable stents, covered stents, and drug eluting stents. The peripheral vascular stents segment has been split into fem-pop artery stents, iliac artery stents, and infrapop artery stents. The coronary artery stents segment held a major share of the global vascular stents market in 2018.
  • In terms of delivery method, the global vascular stents market has been classified into balloon expandable stents and self-expanding stents. The self-expanding stents segment is likely to dominate the global vascular stents market during the forecast period.
  • Based on material, the global vascular stents has been divided into cobalt-chromium stent, platinum-chromium stent, nitinol stent, stainless steel stent, and bioresorbable polymer stent
  • In terms of end user, the global vascular stents market has been categorized into hospitals, cardiac centers, and ambulatory surgical centers. The hospital segment is projected to dominate the global vascular stents market during the forecast period.
  • The market size and forecast for each of these segments have been provided from 2017 to 2027. The CAGR of respective segment has also been provided for the forecast period from 2019 to 2027, considering 2018 as the base year.

Vascular Stents Market: Regional Outlook

  • In terms of region, the global vascular stents market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa)
  • The report provides market size and forecast for each region and country/sub-region from 2017 to 2027. Compound annual growth rates (CAGRs) of each of these regions and countries have also been provided for the forecast period from 2019 to 2027, considering 2018 as the base year. The vascular stents market study also covers the competitive scenario in these regions.

Companies Mentioned in Report

  • Key players in the global vascular stents market have been profiled based on key aspects such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies
  • Major companies profiled in the global vascular stents market report 
    • Abbott Vascular (Abbott Laboratories)
    • Cordis Corporation (A Cardinal Health Company)
    • Medtronic
    • Boston Scientific Corporation
    • BIOTRONIK AG
    • Lifetech Scientific
    • C. R. Bard, Inc. (Becton, Dickinson and Company)
    • Biosensors International Group, Ltd.
    • Cook Medical,
    • W. L. Gore & Associates, Inc.

Vascular Stents Market – Scope of the Report

TMR’s report on the vascular stents market studies the past as well as the current growth trends and opportunities, to gain valuable insights of these indicators for the market over the forecast period from 2019 to 2027. The report provides the overall revenue of the global vascular stents market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global vascular stents market for the forecast period 2019–2027.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the vascular stents market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approach to study various phenomena in the vascular stents market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the vascular stents market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the vascular stents market.

The report also delves into the competition landscape of the vascular stents market. Key players operating in the vascular stents market are identified and each one of these is profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the vascular stents market that are profiled in this report.

Key Questions Answered in Vascular Stents Market Report

  • How does the development of vascular stents provide scope of growth in the vascular stents market?
  • How alliances and partnerships between players are widening the scope of new line of technologies for vascular stents?
  • What are the revenue share projections of key segments under various criteria in the vascular stents market during the forecast period?
  • Which segment is likely to register leading revenue until the end of the forecast period in 2027?
  • How is the evolving health care system in developing countries of Asia Pacific making an impact on the overall vascular stents market?

Vascular Stents Market - Research Objectives and Research Approach

The comprehensive report on the vascular stents market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study and healthcare compliances laid down by accredited agencies in the purview of line of procedure for vascular stents.

For reading comprehensibility, the report is compiled in a chapter-wise layout, with each section further divided into smaller sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the vascular stents market in terms of type, delivery method, material, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2027 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the vascular stents market.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Vascular Stents Market - Segmentation

Type

Coronary Artery Stents

  • Bare Metal Stents
  • Bioresorbable Stents
  • Covered Stents
  • Drug Eluting Stents

Peripheral Vascular Stents

  • Fem-pop Artery Stents
  • Iliac Artery Stents
  • Infrapop Artery Stents

Neurovascular Stents

 

Delivery Method

Balloon Expandable Stents

Self-expanding Stents

Material

Cobalt-Chromium Stent

Platinum-Chromium Stent

Nitinol Stent

Stainless Steel Stent

Bioresorbable Polymer Stent

End User

Hospitals

Cardiac Centers

Ambulatory Surgical Centers

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Vascular Stents Market

4. Market Overview

    4.1. Introduction

        4.1.1. Vascular Stents Market Introduction

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Vascular Stents Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Key Mergers & Acquisitions 

    5.2. Technological Advancements

    5.3. Disease Prevalence & Incidence Rate globally with key countries

    5.4. Vascular Stents Product Mapping

6. Global Vascular Stents Market Analysis and Forecast, by Type 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Type, 2017–2027

        6.3.1. Coronary Artery Stents

            6.3.1.1. Bare Metal Stents

            6.3.1.2. Bioresorbable Stents

            6.3.1.3. Covered Stents

            6.3.1.4. Drug Eluting Stents

        6.3.2. Peripheral Vascular Stents

            6.3.2.1. Fem-pop Artery Stents

            6.3.2.2. Iliac Artery Stents

            6.3.2.3. Infrapop Artery Stents

        6.3.3. Neurovascular Stents

    6.4. Market Attractiveness, by Type 

7. Global Vascular Stents Market Analysis and Forecast, by Delivery Method 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Delivery Method, 2017–2027

        7.3.1. Balloon Expandable Stents

        7.3.2. Self-expanding Stents

    7.4. Market Attractiveness, by Delivery Method 

8. Global Vascular Stents Market Analysis and Forecast, by Material 

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Material, 2017–2027

        8.3.1. Cobalt-Chromium Stent

        8.3.2. Platinum-Chromium Stent

        8.3.3. Nitinol Stent

        8.3.4. Stainless Steel Stent

        8.3.5. Bioresorbable Polymer Stent

    8.4. Market Attractiveness, by Material 

9. Global Vascular Stents Market Analysis and Forecast, by End-user 

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Market Value Forecast, by End-user, 2017–2027

        9.3.1. Hospitals

        9.3.2. Cardiac Centers

        9.3.3. Ambulatory Surgical Centers

    9.4. Market Attractiveness, by End-user 

10. Global Vascular Stents Market Analysis and Forecast, by Region

    10.1. Key Findings

    10.2. Market Value Forecast, by Region

        10.2.1. North America 

        10.2.2. Europe 

        10.2.3. Asia Pacific 

        10.2.4. Latin America 

        10.2.5. Middle East & Africa 

    10.3. Market Attractiveness, by Region

11. North America Vascular Stents Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Type, 2017–2027

        11.2.1. Coronary Artery Stents

            11.2.1.1. Bare Metal Stents

            11.2.1.2. Bioresorbable Stents

            11.2.1.3. Covered Stents

            11.2.1.4. Drug Eluting Stents

        11.2.2. Peripheral Vascular Stents

            11.2.2.1. Fem-pop Artery Stents

            11.2.2.2. Iliac Artery Stents

            11.2.2.3. Infrapop Artery Stents

        11.2.3. Neurovascular Stents

    11.3. Market Value Forecast, by Delivery Method, 2017–2027

        11.3.1. Balloon Expandable Stents

        11.3.2. Self-expanding Stents

    11.4. Market Value Forecast, by Material, 2017–2027

        11.4.1. Cobalt-Chromium Stent

        11.4.2. Platinum-Chromium Stent

        11.4.3. Nitinol Stent

        11.4.4. Stainless Steel Stent

        11.4.5. Bioresorbable Polymer Stent

    11.5. Market Value Forecast, by End-user, 2017–2027

        11.5.1. Hospitals

        11.5.2. Cardiac Centers

        11.5.3. Ambulatory Surgical Centers

    11.6. Market Value Forecast, by Country, 2017–2027

        11.6.1. U.S.

        11.6.2. Canada

    11.7. Market Attractiveness Analysis 

        11.7.1. By Type 

        11.7.2. By Delivery Method 

        11.7.3. By Material 

        11.7.4. By End-user 

        11.7.5. By Country

12. Europe Vascular Stents Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Type, 2017–2027

        12.2.1. Coronary Artery Stents

            12.2.1.1. Bare Metal Stents

            12.2.1.2. Bioresorbable Stents

            12.2.1.3. Covered Stents

            12.2.1.4. Drug Eluting Stents

        12.2.2. Peripheral Vascular Stents

            12.2.2.1. Fem-pop Artery Stents

            12.2.2.2. Iliac Artery Stents

            12.2.2.3. Infrapop Artery Stents

        12.2.3. Neurovascular Stents

    12.3. Market Value Forecast, by Delivery Method, 2017–2027

        12.3.1. Balloon Expandable Stents

        12.3.2. Self-expanding Stents

    12.4. Market Value Forecast, by Material, 2017–2027

        12.4.1. Cobalt-Chromium Stent

        12.4.2. Platinum-Chromium Stent

        12.4.3. Nitinol Stent

        12.4.4. Stainless Steel Stent

        12.4.5. Bioresorbable Polymer Stent

    12.5. Market Value Forecast, by End-user, 2017–2027

        12.5.1. Hospitals

        12.5.2. Cardiac Centers

        12.5.3. Ambulatory Surgical Centers

    12.6. Market Value Forecast, by Country/Sub-region, 2017–2027

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Market Attractiveness Analysis 

        12.7.1. By Type 

        12.7.2. By Delivery Method 

        12.7.3. By Material 

        12.7.4. By End-user 

        12.7.5. By Country/Sub-region

13. Asia Pacific Vascular Stents Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Type, 2017–2027

        13.2.1. Coronary Artery Stents

            13.2.1.1. Bare Metal Stents

            13.2.1.2. Bioresorbable Stents

            13.2.1.3. Covered Stents

            13.2.1.4. Drug Eluting Stents

        13.2.2. Peripheral Vascular Stents

            13.2.2.1. Fem-pop Artery Stents

            13.2.2.2. Iliac Artery Stents

            13.2.2.3. Infrapop Artery Stents

        13.2.3. Neurovascular Stents

    13.3. Market Value Forecast, by Delivery Method, 2017–2027

        13.3.1. Balloon Expandable Stents

        13.3.2. Self-expanding Stents

    13.4. Market Value Forecast, by Material, 2017–2027

        13.4.1. Cobalt-Chromium Stent

        13.4.2. Platinum-Chromium Stent

        13.4.3. Nitinol Stent

        13.4.4. Stainless Steel Stent

        13.4.5. Bioresorbable Polymer Stent

    13.5. Market Value Forecast, by End-user, 2017–2027

        13.5.1. Hospitals

        13.5.2. Cardiac Centers

        13.5.3. Ambulatory Surgical Centers

    13.6. Market Value Forecast, by Country/Sub-region, 2017–2027

        13.6.1. China

        13.6.2. Japan

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Market Attractiveness Analysis 

        13.7.1. By Type 

        13.7.2. By Delivery Method 

        13.7.3. By Material 

        13.7.4. By End-user 

        13.7.5. By Country/Sub-region

14. Latin America Vascular Stents Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Type, 2017–2027

        14.2.1. Coronary Artery Stents

            14.2.1.1. Bare Metal Stents

            14.2.1.2. Bioresorbable Stents

            14.2.1.3. Covered Stents

            14.2.1.4. Drug Eluting Stents

        14.2.2. Peripheral Vascular Stents

            14.2.2.1. Fem-pop Artery Stents

            14.2.2.2. Iliac Artery Stents

            14.2.2.3. Infrapop Artery Stents

        14.2.3. Neurovascular Stents

    14.3. Market Value Forecast, by Delivery Method, 2017–2027

        14.3.1. Balloon Expandable Stents

        14.3.2. Self-expanding Stents

    14.4. Market Value Forecast, by Material, 2017–2027

        14.4.1. Cobalt-Chromium Stent

        14.4.2. Platinum-Chromium Stent

        14.4.3. Nitinol Stent

        14.4.4. Stainless Steel Stent

        14.4.5. Bioresorbable Polymer Stent

    14.5. Market Value Forecast, by End-user, 2017–2027

        14.5.1. Hospitals

        14.5.2. Cardiac Centers

        14.5.3. Ambulatory Surgical Centers

    14.6. Market Value Forecast, by Country/Sub-region, 2017–2027

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Market Attractiveness Analysis 

        14.7.1. By Type 

        14.7.2. By Delivery Method 

        14.7.3. By Material 

        14.7.4. By End-user 

        14.7.5. By Country/Sub-region

15. Middle East & Africa Vascular Stents Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Market Value Forecast, by Type, 2017–2027

        15.2.1. Coronary Artery Stents

            15.2.1.1. Bare Metal Stents

            15.2.1.2. Bioresorbable Stents

            15.2.1.3. Covered Stents

            15.2.1.4. Drug Eluting Stents

        15.2.2. Peripheral Vascular Stents

            15.2.2.1. Fem-pop Artery Stents

            15.2.2.2. Iliac Artery Stents

            15.2.2.3. Infrapop Artery Stents

        15.2.3. Neurovascular Stents

    15.3. Market Value Forecast, by Delivery Method, 2017–2027

        15.3.1. Balloon Expandable Stents

        15.3.2. Self-expanding Stents

    15.4. Market Value Forecast, by Material, 2017–2027

        15.4.1. Cobalt-Chromium Stent

        15.4.2. Platinum-Chromium Stent

        15.4.3. Nitinol Stent

        15.4.4. Stainless Steel Stent

        15.4.5. Bioresorbable Polymer Stent

    15.5. Market Value Forecast, by End-user, 2017–2027

        15.5.1. Hospitals

        15.5.2. Cardiac Centers

        15.5.3. Ambulatory Surgical Centers

    15.6. Market Value Forecast, by Country/Sub-region, 2017–2027

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of Middle East & Africa

    15.7. Market Attractiveness Analysis 

        15.7.1. By Type 

        15.7.2. By Delivery Method 

        15.7.3. By Material 

        15.7.4. By End-user 

        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Player – Competition Matrix (by Tier and Size of companies)

    16.2. Market Share Analysis by Company (2018)

    16.3. Company Profiles

        16.3.1. Abbott Vascular (Abbott Laboratories)

            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.1.2. Growth Strategies

            16.3.1.3. SWOT Analysis

        16.3.2. Cordis Corporation (A Cardinal Health Company)

            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.2.2. Growth Strategies

            16.3.2.3. SWOT Analysis

        16.3.3. Medtronic

            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.3.2. Growth Strategies

            16.3.3.3. SWOT Analysis

        16.3.4. Boston Scientific Corporation

            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.4.2. Growth Strategies

            16.3.4.3. SWOT Analysis

        16.3.5. BIOTRONIK AG

            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.5.2. Growth Strategies

            16.3.5.3. SWOT Analysis

        16.3.6. Lifetech Scientific 

            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.6.2. Growth Strategies

            16.3.6.3. SWOT Analysis

        16.3.7. C. R. Bard, Inc. (Becton, Dickinson and Company)

            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.7.2. Growth Strategies

            16.3.7.3. SWOT Analysis

        16.3.8. Biosensors International Group, Ltd. 

            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.8.2. Growth Strategies

            16.3.8.3. SWOT Analysis

        16.3.9. Cook Medical 

            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.9.2. Growth Strategies

            16.3.9.3. SWOT Analysis

        16.3.10. W. L. Gore & Associates, Inc. 

            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.10.2. Growth Strategies

            16.3.10.3. SWOT Analysis

List of Tables

Table 01: Global Vascular Stents Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 02: Global Vascular Stents Market Value (US$ Mn) Forecast, by Coronary Artery Stents, 2017–2027

Table 03: Global Vascular Stents Market Value (US$ Mn) Forecast, by Peripheral Vascular Stents, 2017–2027

Table 04: Global Vascular Stents Market Value (US$ Mn) Forecast, by Delivery Method, 2017–2027

Table 05: Global Vascular Stents Market Value (US$ Mn) Forecast, by Material, 2017–2027

Table 06: Global Vascular Stents Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 07: Global Vascular Stents Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 08: North America Vascular Stents Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 09: North America Vascular Stents Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 10: North America Vascular Stents Market Value (US$ Mn) Forecast, by Coronary Artery Stents, 2017–2027

Table 11: North America Vascular Stents Market Value (US$ Mn) Forecast, by Peripheral Vascular Stents, 2017–2027

Table 12: North America Vascular Stents Market Value (US$ Mn) Forecast, by Delivery Method, 2017–2027

Table 13: Global Vascular Stents Market Value (US$ Mn) Forecast, by Material, 2017–2027

Table 14: North America Vascular Stents Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 15: Europe Vascular Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 16: Europe Vascular Stents Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 17: Europe Vascular Stents Market Value (US$ Mn) Forecast, by Coronary Artery Stents, 2017–2027

Table 18: Europe Vascular Stents Market Value (US$ Mn) Forecast, by Peripheral Vascular Stents, 2017–2027

Table 19: Europe Vascular Stents Market Value (US$ Mn) Forecast, by Delivery Method, 2017–2027

Table 20: Global Vascular Stents Market Value (US$ Mn) Forecast, by Material, 2017–2027

Table 21: Europe Vascular Stents Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 22: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 23: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 24: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast, by Coronary Artery Stents, 2017–2027

Table 25: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast, by Peripheral Vascular Stents, 2017–2027

Table 26: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast, by Delivery Method, 2017–2027

Table 27: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast, by Material, 2017–2027

Table 28: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 29: Latin America Vascular Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 30: Latin America Vascular Stents Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 31: Latin America Vascular Stents Market Value (US$ Mn) Forecast, by Coronary Artery Stents, 2017–2027

Table 32: Latin America Vascular Stents Market Value (US$ Mn) Forecast, by Peripheral Vascular Stents, 2017–2027

Table 33: Latin America Vascular Stents Market Value (US$ Mn) Forecast, by Delivery Method, 2017–2027

Table 34: Latin America Vascular Stents Market Value (US$ Mn) Forecast, by Material, 2017–2027

Table 35: Latin America Vascular Stents Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 36: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 37: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 38: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast, by Coronary Artery Stents, 2017–2027

Table 39: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast, by Peripheral Vascular Stents, 2017–2027

Table 40: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast, by Delivery Method, 2017–2027

Table 41: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast, by Material, 2017–2027

Table 42: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast, by End-user, 2017–2027

List of Figures

Figure 01: Global Vascular Stents Market Value (US$ Mn) Forecast, 2017–2027

Figure 02: Global Vascular Stents Market Value Share, by Type, 2018

Figure 03: Global Vascular Stents Market Value Share, by Delivery Method, 2018

Figure 04: Global Vascular Stents Market Value Share, by Material, 2018

Figure 05: Global Vascular Stents Market Value Share, by End-user, 2018

Figure 06: Global Vascular Stents Market Value Share, by region, 2018

Figure 07: Global Vascular Stents Market Value Share Analysis, by Type, 2018 and 2027

Figure 08: Global Vascular Stents Market Attractiveness Analysis, by Type, 2019–2027

Figure 09: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Coronary Artery Stents , 2017–2027

Figure 10: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Peripheral Vascular Stents, 2017–2027

Figure 11: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Neurovascular Stents, 2017–2027

Figure 12: Global Vascular Stents Market Value Share Analysis, by Delivery Method, 2018 and 2027

Figure 13: Global Vascular Stents Market Attractiveness Analysis, by Delivery Method, 2019–2027

Figure 14: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Balloon Expandable Stents, 2017–2027

Figure 15: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Self-expanding Stents, 2017–2027

Figure 16: Global Vascular Stents Market Value Share Analysis, by Material, 2018 and 2027

Figure 17: Global Vascular Stents Market Attractiveness Analysis, by Material, 2019–2027

Figure 18: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cobalt-Chromium Stent, 2017–2027

Figure 19: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Platinum-Chromium Stent, 2017–2027

Figure 20: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Nitinol Stent, 2017–2027

Figure 21: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Stainless Steel Stent, 2017–2027

Figure 22: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Bioresorbable Polymer Stent, 2017–2027

Figure 23: Global Vascular Stents Market Value Share Analysis, by End-user, 2018 and 2027

Figure 24: Global Vascular Stents Market Attractiveness Analysis, by End-user, 2019–2027

Figure 25: Global Vascular Stents Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Hospitals, 2017–2027

Figure 26: Global Vascular Stents Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Cardiac Centers, 2017–2027

Figure 27: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2017–2027

Figure 28: Global Vascular Stents Market Value Share, by Region, 2018 and 2027 

Figure 29: Global Vascular Stents Market Attractiveness, by Region, 2019–2027

Figure 30: North America Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 31: North America Vascular Stents Market Value Share (%) Analysis, by Country, 2018 & 2027

Figure 32: North America Vascular Stents Market Attractiveness Analysis, by Country, 2019?2027

Figure 33: North America Vascular Stents Market Value Share Analysis, by Type, 2018 and 2027

Figure 34: North America Vascular Stents Market Attractiveness Analysis, by Type, 2019–2027

Figure 35: North America Vascular Stents Market Value Share Analysis, by Delivery Method, 2018 and 2027

Figure 36: North America Vascular Stents Market Attractiveness Analysis, by Delivery Method, 2019–2027

Figure 37: North America Vascular Stents Market Value Share Analysis, by Material, 2018 and 2027

Figure 38: North America Vascular Stents Market Attractiveness Analysis, by Material, 2019–2027

Figure 39: North America Vascular Stents Market Value Share Analysis, by End-user, 2018 and 2027

Figure 40: North America Vascular Stents Market Attractiveness Analysis, by End-user, 2019–2027

Figure 41: Europe Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 42: Europe Vascular Stents Market Value Share (%) Analysis, by Country/Sub-region, 2018 & 2027

Figure 43: Europe Vascular Stents Market Attractiveness Analysis, by Country/Sub-region, 2019?2027

Figure 44: Europe Vascular Stents Market Value Share Analysis, by Type, 2018 and 2027

Figure 45: Europe Vascular Stents Market Attractiveness Analysis, by Type, 2019–2027

Figure 46: Europe Vascular Stents Market Value Share Analysis, by Delivery Method, 2018 and 2027

Figure 47: Europe Vascular Stents Market Attractiveness Analysis, by Delivery Method, 2019–2027

Figure 48: Europe Vascular Stents Market Value Share Analysis, by Material, 2018 and 2027

Figure 49: Europe Vascular Stents Market Attractiveness Analysis, by Material, 2019–2027

Figure 50: Europe Vascular Stents Market Value Share Analysis, by End-user, 2018 and 2027

Figure 51: Europe Vascular Stents Market Attractiveness Analysis, by End-user, 2019–2027

Figure 52: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 53: Asia Pacific Vascular Stents Market Value Share (%) Analysis, by Country/Sub-region, 2018 & 2027

Figure 54: Asia Pacific Vascular Stents Market Attractiveness Analysis, by Country/Sub-region, 2019?2027

Figure 55: Asia Pacific Vascular Stents Market Value Share Analysis, by Type, 2018 and 2027

Figure 56: Asia Pacific Vascular Stents Market Attractiveness Analysis, by Type, 2019–2027

Figure 57: Asia Pacific Vascular Stents Market Value Share Analysis, by Delivery Method, 2018 and 2027

Figure 58: Asia Pacific Vascular Stents Market Attractiveness Analysis, by Delivery Method, 2019–2027

Figure 59: Asia Pacific Vascular Stents Market Value Share Analysis, by Material, 2018 and 2027

Figure 60: Asia Pacific Vascular Stents Market Attractiveness Analysis, by Material, 2019–2027

Figure 61: Asia Pacific Vascular Stents Market Value Share Analysis, by End-user, 2018 and 2027

Figure 62: Asia Pacific Vascular Stents Market Attractiveness Analysis, by End-user, 2019–2027

Figure 63: Latin America Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 64: Latin America Vascular Stents Market Value Share (%) Analysis, by Country/Sub-region, 2018 & 2027

Figure 65: Latin America Vascular Stents Market Attractiveness Analysis, by Country/Sub-region, 2019?2027

Figure 66: Latin America Vascular Stents Market Value Share Analysis, by Type, 2018 and 2027

Figure 67: Latin America Vascular Stents Market Attractiveness Analysis, by Type, 2019–2027

Figure 68: Latin America Vascular Stents Market Value Share Analysis, by Delivery Method, 2018 and 2027

Figure 69: Latin America Vascular Stents Market Attractiveness Analysis, by Delivery Method, 2019–2027

Figure 70: Latin America Vascular Stents Market Value Share Analysis, by Material, 2018 and 2027

Figure 71: Latin America Vascular Stents Market Attractiveness Analysis, by Material, 2019–2027

Figure 72: Latin America Vascular Stents Market Value Share Analysis, by End-user, 2018 and 2027

Figure 73: Latin America Vascular Stents Market Attractiveness Analysis, by End-user, 2019–2027

Figure 74: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 75: Middle East & Africa Vascular Stents Market Value Share (%) Analysis, by Country/Sub-region, 2018 & 2027

Figure 76: Middle East & Africa Vascular Stents Market Attractiveness Analysis, by Country/Sub-region, 2019?2027

Figure 77: Middle East & Africa Vascular Stents Market Value Share Analysis, by Type, 2018 and 2027

Figure 78: Middle East & Africa Vascular Stents Market Attractiveness Analysis, by Type, 2019–2027

Figure 79: Middle East & Africa Vascular Stents Market Value Share Analysis, by Delivery Method, 2018 and 2027

Figure 80: Middle East & Africa Vascular Stents Market Attractiveness Analysis, by Delivery Method, 2019–2027

Figure 81: Middle East & Africa Vascular Stents Market Value Share Analysis, by Material, 2018 and 2027

Figure 82: Middle East & Africa Vascular Stents Market Attractiveness Analysis, by Material, 2019–2027

Figure 83: Middle East & Africa Vascular Stents Market Value Share Analysis, by End-user, 2018 and 2027

Figure 84: Middle East & Africa Vascular Stents Market Attractiveness Analysis, by End-user, 2019–2027

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Vascular Stents Market